RNS Number : 9619X
  Northwest Biotherapeutics Inc
  01 July 2008
   

 For Immediate Release  1 July 2008

            

    Northwest Biotherapeutics
    ("NWBT" or "the Company")

    Board Change


    Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announces the resignation, effective July 1, 2008, of R. Steve
Harris as a non-executive member of the Board of Directors of the Company.  The Company expects to announce a replacement shortly.

    Linda F. Powers, Chairperson of the Company's Board of Directors, commented: "We would like to thank Steve for his contributions to the
Company."

    Steve Harris added: "I wish Northwest Biotherapeutics every success in the continuing development of DCVax�-Brain and other applications
of the Company's very promising technology."

    For further information, please contact:

 Northwest Biotherapeutics
 Anthony P. Deasey, Chief Financial Officer                    +1 240-497-9024




 Buchanan Communications
 Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane         +44 (0)20 7466 5000
 Johnson / Catherine Breen 

 Collins Stewart
 Adam Cowen/Tim Mickley                                    +44 (0)20 7523 8230



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
BOABCGDLIXXGGIG

Northw.Bio Regs (LSE:NWBS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Northw.Bio Regs 차트를 더 보려면 여기를 클릭.
Northw.Bio Regs (LSE:NWBS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Northw.Bio Regs 차트를 더 보려면 여기를 클릭.